Athena Vale
Antipsychotics are a class of drugs used to treat schizophrenia and other psychotic disorders. They are associated with a wide range of side effects, including movement disorders such as akathisia, dystonia, parkinsonism, and tardive dyskinesia. These movement disorders can result in involuntary muscle movements and twitching, which in some cases may become permanent. While the newer antipsychotics have a lower propensity to cause acute extrapyramidal side effects, they may still be associated with muscle twitching and tardive dyskinesia. Various treatments for antipsychotic-induced movement disorders have been proposed, including lowering the dosage of the antipsychotic, anticholinergic agents, benzodiazepines, and beta-adrenergic blockers.
| Characteristics | Values |
|---|---|
| Muscle twitching | Caused by tardive dyskinesia, a side effect of antipsychotics |
| Cause of muscle twitching | Interference with the brain chemical dopamine, which controls movement |
| Treatment for muscle twitching | Lowering the dosage of antipsychotics, switching to second-generation antipsychotics, or adding anticholinergic agents or benzodiazepines to the treatment |
| Permanence of muscle twitching | May become permanent or persist even after discontinuing antipsychotics; another medication, propranolol, may help with the shaking |
| Risk factors | Higher risk with moderate to high doses of antipsychotics, younger patients, and male patients |
| Other side effects | Dystonia, oculogyric crisis, akathisia, Parkinsonism, neuroleptic malignant syndrome, sedation, heart problems, and more |
Explore related products
What You'll Learn
Antipsychotics and permanent muscle twitching
Antipsychotic drugs are commonly used to treat schizophrenia and other psychotic disorders. They are also used to treat bipolar disorder, major depressive disorder, and other conditions. While these drugs are therapeutically effective, they are associated with a range of side effects, including movement disorders.
These movement disorders can be disabling and distressing, causing behavioural disturbances, non-adherence to treatment, and exacerbation of psychosis. They can also add to the stigma of psychiatric illness. The most common movement disorders associated with antipsychotics include akathisia, dystonia, parkinsonism, and tardive dyskinesia.
Akathisia involves subjective motor restlessness and inner tension, which can be distressing and lead to poor adherence to treatment. Dystonia is characterised by involuntary muscle contractions that can lead to twisted and distorted postures, with the muscles of the head and neck being most commonly affected. Parkinsonism refers to a group of symptoms similar to Parkinson's disease, including muscle stiffness, difficulty making facial expressions, and tremors. Tardive dyskinesia involves involuntary muscle movements and twitching.
It has been known since the 1950s that antipsychotics can lead to involuntary muscular movements that may become permanent, known as tardive dyskinesia or tardive dystonia. While newer antipsychotics were believed to cause fewer movement disorders, recent studies suggest that the rates of tardive dyskinesia with these drugs are "more similar" to older antipsychotics than previously thought.
Some individuals who have experienced muscle twitching while taking antipsychotics report that the twitching has persisted even after discontinuing the medication. In some cases, additional medications such as propranolol or cogentin may be prescribed to help manage the twitching, but these may only provide partial relief.
Victoza and Muscle Atrophy: What's the Link?
You may want to see also
Explore related products
Antipsychotics and tardive dyskinesia
Antipsychotics are a class of drugs used to treat psychotic disorders such as schizophrenia, psychotic episodes, bipolar disorder, and major depressive disorder. They are also used to treat certain conditions in children and adolescents, such as bipolar disorder and major depressive disorder. While antipsychotics are effective in treating these disorders, they are associated with a wide range of side effects, including movement disorders.
Tardive dyskinesia (TD) is a movement disorder that is a potential side effect of taking antipsychotics. It is characterised by unintended rhythmic motions that are not smooth or controlled. TD is believed to be caused by the way antipsychotics interfere with dopamine, a vital brain chemical involved in regulating movement. When antipsychotics block dopamine receptors (D2 receptors) in the central nervous system, it results in a lack of dopamine, leading to uncontrolled movements.
The risk of developing TD varies depending on the type of antipsychotic medication. First-generation antipsychotics, also known as typical antipsychotics, are known to have a higher risk of causing TD compared to second-generation antipsychotics, or atypical antipsychotics. This is because first-generation antipsychotics bind more tightly to the D2 receptors and are more potent antagonists. However, it is important to note that even second-generation antipsychotics can increase the risk of TD, although at a lower rate.
The prevalence of TD in patients taking antipsychotics is estimated to be between 16% and 50%, with about 60% of cases being mild and about 3% being extremely severe. It is important to consider the potential risks and benefits when prescribing antipsychotics, as TD can significantly impact a patient's quality of life. Additionally, certain populations, such as older adults, women, and people of African descent, may be at an increased risk of developing TD.
While there is no cure for TD, lowering the dosage of antipsychotics may help manage the symptoms. However, this strategy may not be clinically feasible for all patients, especially those with acute illnesses. Other treatment options include the use of benzodiazepines, beta-blockers, and alpha-2 agonists. Early intervention may also be key in preventing or mitigating the severity of TD symptoms.
Mold Toxins: Can They Damage Your Muscles?
You may want to see also
Explore related products
Antipsychotics and dystonia
Antipsychotics are commonly used in the treatment of schizophrenia, psychotic episodes, and other conditions. While they are therapeutically effective, they are associated with a wide range of side effects, including movement disorders.
Dystonia is a movement disorder characterised by involuntary movements that can range from fleeting disturbances to sustained abnormal postures. Dystonia can be induced by drug treatment, particularly by the use of antipsychotics, and is known as antipsychotic-induced dystonia or drug-induced dystonia. This occurs when dopamine D2 receptors are blocked, which is particularly relevant to antipsychotics as they interfere with the brain chemical dopamine.
Antipsychotic-induced dystonia can manifest as sustained muscle contractions leading to twisting, abnormal, or distorted postures. It typically occurs early in the course of treatment, usually within 96 hours of starting or after a rapid increase in dosage. The muscles of the head and neck are most commonly affected, but dystonia may appear in all muscle groups. Symptoms can include torticollis, oculogyric crisis, difficulties in chewing and swallowing, and spasms of the masseter muscle. A tense tongue or throat may indicate a moderate form of acute dystonia.
Younger patients, particularly younger males, are at a higher risk of developing antipsychotic-induced dystonia. The risk decreases with age, and it is rare in patients over 45 years old. Other risk factors include a history of acute dystonia, cocaine use, and the use of high-potency antipsychotics.
The treatment for antipsychotic-induced dystonia involves lowering the dosage of the antipsychotic or switching to atypical antipsychotics, which have a lower propensity to cause dystonia. Anticholinergic drugs, such as anticholinergic agents or benztropine mesylate, are often used to treat dystonia. In some cases, benzodiazepines or beta-blockers may also be prescribed.
Ammonia Poisoning: Muscle Aches and Pains Explained
You may want to see also
Explore related products
Antipsychotics and akathisia
Antipsychotics are a class of drugs used to treat psychotic disorders, such as schizophrenia, psychotic episodes, bipolar disorder, depression, and other conditions. While they are effective in treating these disorders, antipsychotics are associated with a range of side effects, including movement disorders. One of the most common movement disorders associated with antipsychotics is akathisia.
Akathisia is characterised by subjective and objective psychomotor restlessness, a compelling urge to move, especially the lower limbs, and feelings of inner tension and discomfort. It can cause extreme distress and anxiety in those affected and has been linked to a high risk of self-harm or suicidal behaviour. The observable symptoms of akathisia include the inability to sit, stand, or lie still. When sitting, the legs of the affected person tend to swing, cross and uncross, or tramp up and down. When standing, they tend to shift their weight from one foot to the other or pace back and forth.
Akathisia is often associated with the use of antipsychotic medications, particularly first-generation antipsychotics (FGAs) or high-potency and high-dose drugs within this class. It typically occurs during the early days of treatment with antipsychotics or after an increase in dosage. In most cases, it lasts for fewer than six months, but it can become chronic, persisting for more than six months.
The treatment of antipsychotic-induced akathisia typically involves reducing the dosage of the antipsychotic medication or switching to an antipsychotic with a lower risk of causing akathisia. Anticholinergic agents, such as trihexyphenidyl, and benzodiazepines, such as clonazepam, are also used as first-line treatments. In resistant cases, propranolol, diazepam, or amantadine may be required. Additionally, beta-blockers, 5HT2A antagonists, vitamin B6, and other adjuvant medications have been found effective.
It is important to carefully evaluate and manage the symptoms of akathisia to optimise the balance between the potential risks and benefits of antipsychotic treatment. While akathisia is a recognised side effect of antipsychotics, it has been largely overlooked, and its clinical presentation was delineated in the 1980s.
Knee and Thigh Pain: Causes and Solutions
You may want to see also
Explore related products
![On the Production and Suppression of Muscular Twitchings and Hypersensitiveness of the Skin by Electrolytes , Volume 10, Issue 1 1903 [Leather Bound]](https://m.media-amazon.com/images/I/617DLHXyzlL._AC_UL320_.jpg)
Antipsychotics and oculogyric crisis
Antipsychotics are the primary treatment for schizophrenia and other psychotic disorders. However, they are associated with a wide range of side effects, including movement disorders. Oculogyric crisis (OGC) is one such rare movement disorder that affects the muscles controlling eye movement, causing the eyes to turn suddenly, resulting in an inability to control one's gaze. This condition can be unpleasant and dangerous, particularly in situations that require focused vision, such as crossing the road.
OGC is an acute dystonic reaction commonly observed with the administration of typical antipsychotics and rarely reported with atypical antipsychotics. It is characterised by upward eye-rolling and fixation, lasting from seconds to minutes, and can be accompanied by anxiety. The condition is generally related to the initiation or increase of the dosage of typical antipsychotics. However, it has also been reported with atypical antipsychotics, including risperidone, olanzapine, quetiapine, amisulpride, aripiprazole, and haloperidol.
The treatment for OGC involves the use of oral anticholinergics, which are typically effective. In some cases, a reduction in dosage or discontinuation of the antipsychotic agent may be necessary, followed by switching to safer alternatives or clozapine. Early detection and treatment of OGC can improve medication adherence and enhance patients' quality of life.
While OGC is primarily associated with antipsychotic usage, it can also be related to other neurological diseases with a genetic basis or associated with movement disorders. Additionally, focal brain lesions affecting the basal ganglia or midbrain can compromise the nigrostriatal pathway and lead to OGC. The most important differential diagnosis for OGC is frontal lobe epilepsy, which is characterised by lateral forced head version during eye deviation.
To summarise, OGC is a rare but unpleasant and potentially dangerous side effect of antipsychotic medication. It involves the sudden, uncontrollable movement of the eyes, typically upwards, and can last from seconds to minutes. Effective treatments are available, and early detection can improve patient outcomes. While typically associated with typical antipsychotics, OGC has also been reported with some atypical antipsychotics, underscoring the importance of careful evaluation and management of antipsychotic side effects.
Ranexa and Muscle Pain: What's the Link?
You may want to see also
Frequently asked questions
Yes, it is known that antipsychotics can cause involuntary muscle movements, including muscle twitching.
Antipsychotics can cause tardive dyskinesia, which involves involuntary muscle movements and twitching. Dystonia, or sustained contractions of muscles leading to twisting and distorted postures, can also occur.
Yes, muscle stiffness and postural distortion can occur, which can be both painful and uncomfortable. Other side effects include oculogyric crisis, where the muscles that control eye movements are affected, and muscle spasms of the head, neck and tongue.
Anticholinergic agents, such as trihexyphenidyl, are often used to treat akathisia, a movement disorder that can be caused by antipsychotics. Benzodiazepines are also used as a first-line treatment.
Newer antipsychotics have a lower propensity to cause acute extrapyramidal side effects and tardive dyskinesia. However, it is important to note that the risk of movement disorders is still present with these newer medications.
